Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuya Tsunoda

Showing results (21-30 of 130) with videos related to

Pageof 13
Sort By:
Frontiers in Immunology|December 20, 2023
Soluble PD-L1 changes in advanced non-small cell lung cancer patients treated with PD-1 inhibitors: an individual patient data meta-analysisTakashi Shimizu, Eisuke Inoue, Ryotaro Ohkuma, et al.
Cancer Diagnosis & Prognosis|May 6, 2024
Efficacy of Recombinant Methioninase on Late-stage Patient Cancer in the Histoculture Drug Response Assay (HDRA) as a Potential Functional Biomarker of Sensitivity to Methionine-restriction Therapy in the ClinicYutaro Kubota, Masato Sasaki, Qinghong Han, et al.
Japanese Journal of Cancer Research : Gann|June 25, 2002
Dose of adenoviral vectors expressing interleukin-2 plays an important role in combined gene therapy with cytosine deaminase/5-fluorocytosine: preclinical considerationMikihito Nakamori, Makoto Iwahashi, Kentaro Ueda, et al.
Endoscopy International Open|August 20, 2016
Idiopathic perforation of acalculous gallbladder after insertion of a transpapillary pancreatic stentTomoko Katagiri, Atsushi Irisawa, Hiroto Wakabayashi, et al.
Cancer Research|June 3, 2005
Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2Satoshi Wada, Takuya Tsunoda, Toshiyuki Baba, et al.
Cancer Diagnosis & Prognosis|November 6, 2023
Recombinant-methioninase-producing <i>Escherichia coli</i> Instilled in the Microbiome Inhibits Triple-negative Breast Cancer in an Orthotopic Cell-line Mouse ModelYutaro Kubota, Qinghong Han, Sei Morinaga, et al.
Cancer Science|May 3, 2008
Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinomaYoshiki Mizukami, Koji Kono, Yataro Daigo, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2004
Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide-pulsed dendritic cellsKenji Matsuda, Takuya Tsunoda, Hajime Tanaka, et al.
Cancer Science|September 11, 2012
Clinical phase I study of elpamotide, a peptide vaccine for vascular endothelial growth factor receptor 2, in patients with advanced solid tumorsIsamu Okamoto, Tokuzo Arao, Masaki Miyazaki, et al.
Cancer Science|November 26, 2009
Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancerMotoki Miyazawa, Ryuji Ohsawa, Takuya Tsunoda, et al.
Pageof 13

Showing results (21-30 of 130) with videos related to

Sort By:
Pageof 13
Frontiers in Immunology|December 20, 2023
Soluble PD-L1 changes in advanced non-small cell lung cancer patients treated with PD-1 inhibitors: an individual patient data meta-analysisTakashi Shimizu, Eisuke Inoue, Ryotaro Ohkuma, et al.
Cancer Diagnosis & Prognosis|May 6, 2024
Efficacy of Recombinant Methioninase on Late-stage Patient Cancer in the Histoculture Drug Response Assay (HDRA) as a Potential Functional Biomarker of Sensitivity to Methionine-restriction Therapy in the ClinicYutaro Kubota, Masato Sasaki, Qinghong Han, et al.
Japanese Journal of Cancer Research : Gann|June 25, 2002
Dose of adenoviral vectors expressing interleukin-2 plays an important role in combined gene therapy with cytosine deaminase/5-fluorocytosine: preclinical considerationMikihito Nakamori, Makoto Iwahashi, Kentaro Ueda, et al.
Endoscopy International Open|August 20, 2016
Idiopathic perforation of acalculous gallbladder after insertion of a transpapillary pancreatic stentTomoko Katagiri, Atsushi Irisawa, Hiroto Wakabayashi, et al.
Cancer Research|June 3, 2005
Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2Satoshi Wada, Takuya Tsunoda, Toshiyuki Baba, et al.
Cancer Diagnosis & Prognosis|November 6, 2023
Recombinant-methioninase-producing <i>Escherichia coli</i> Instilled in the Microbiome Inhibits Triple-negative Breast Cancer in an Orthotopic Cell-line Mouse ModelYutaro Kubota, Qinghong Han, Sei Morinaga, et al.
Cancer Science|May 3, 2008
Detection of novel cancer-testis antigen-specific T-cell responses in TIL, regional lymph nodes, and PBL in patients with esophageal squamous cell carcinomaYoshiki Mizukami, Koji Kono, Yataro Daigo, et al.
Cancer Immunology, Immunotherapy : CII|January 22, 2004
Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide-pulsed dendritic cellsKenji Matsuda, Takuya Tsunoda, Hajime Tanaka, et al.
Cancer Science|September 11, 2012
Clinical phase I study of elpamotide, a peptide vaccine for vascular endothelial growth factor receptor 2, in patients with advanced solid tumorsIsamu Okamoto, Tokuzo Arao, Masaki Miyazaki, et al.
Cancer Science|November 26, 2009
Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancerMotoki Miyazawa, Ryuji Ohsawa, Takuya Tsunoda, et al.
Pageof 13